-

Europe's Top 5 Aerospace & Defense Companies Report 2022: Strategic Factor Analysis Summary (SFAS) Framework Analysis of Airbus, BAE Systems, Rolls Royce, Safran, Leonardo - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe's Top 5 Aerospace & Defense Companies - 2022 - Strategic Factor Analysis Summary (SFAS) Framework Analysis - Airbus, BAE Systems, Rolls Royce, Safran, Leonardo" report has been added to ResearchAndMarkets.com's offering.

The 2022 edition of the report provides a comparative SFAS framework analysis, developed originally by Wheelen & Hunger, on Europe's Top 5 A&D Primes based on a holistic analysis of their strategic market positioning and degrees of responsiveness to the internal & external environments respectively amid a rapidly evolving industry, global macroeconomy and market landscape.

The objective of the analysis is to assess as to how favorably is each company positioned against the prevailing market backdrop and how responsive it is to the nature & pace of changes taking place within its internal and external environment respectively.

The framework generates an insightful strategic snapshot and a quantiative SFAS score for each OEM by identifying, weighing, prioritizing & ranking significant strategic factors present in the internal & external environments through an Internal Factor Analysis Summary (IFAS) matrix & External Factor Analysis Summary (EFAS) matrix respectively.

These strategic factors are then ranked based on their strategic significance & potential degree of impact along-with each respective company's corresponding degree of responsiveness to these factors.

The final Strategic Factor Analysis Summary (SFAS) matrix amalgamates the IFAS & EFAS matrices into a single matrix followed by a re-evaluation & second level ranking & responsiveness rating, which leads to the generation of an overall score, thus, providing a holistic, overarching strategic view on each industry OEM.

The numeric SFAS scores and the corresponding analysis produced by the framework, thus, are highly useful for competitive & comparative analysis on industry players from a current as well as near term perspective with the framework analyzing the ability of each OEM to be able to create & capitalize on potential growth opportunities effectively by harnessing & navigating the changing market & technology landscape effectively while leveraging structural & core strengths and negating threats & overcoming challenges simultaneously.

SFAS, as a framework, thus, scores significantly over the traditional SWOT analysis framework, in terms, of its ability to quantify a range of strategic factors based on the nature & potential degree of effect of each strategic factor being analyzed, thereby, making it a much more effective tool for competitive assessment and comparative analysis of industry players.

For Whom:

  • Key Decision-Makers
  • Program Managers, Defense Departments & Defense Procurement Executives
  • Top Management of Industry Players & Other Companies
  • Industry OEMs
  • Suppliers, Vendors, Technology & MRO Services Providers and other Key Players in the Industry Value Chain
  • Existing & potential Investors
  • Industry & Company Analysts
  • M&A Advisory Firms
  • Strategy & Management Consulting Firms
  • PE Firms, Venture Capitalists and Financing & Leasing Companies
  • Researchers and all those associated with the industry

Key Topics Covered:

Section - 1 Business Structure & Snapshot

a) Founded

b) Headquartered

c) Business Segments

d) Employees

e) Business Portfolio and Key Competitors

f) Market Capitalization

g) Key Executives

h) Shareholding/Ownership Pattern & Structure

Section - 2 Financial Performance Snapshot

1. Revenue Base & Growth Trend

2. Revenues Split by Key Business Segments

3. Revenues Split by Key Geographic Markets & Regions

4. Gross Earnings & Margin Trend

5. Operating Earnings & Operating Margin Trend

6. Return on Sales Trend

7. Profitability Growth Trend

8. Cash Flow from Operations

9. R&D Expenditure Trend

10.CAPEX Trend

Section - 3 Internal Factor Analysis Summary (IFAS) Matrix - For each of the Europe's Top 5 A&D Primes

  • Quantified Strategic Factors categorized under Strengths
  • Quantified Strategic Factors categorized under Weaknesses

Section - 4 External Factor Analysis Summary (EFAS) Matrix

  • Quantified Strategic Factors categorized under Opportunities
  • Quantified Strategic Factors categorized under Threats

Section - 5 Strategic Factor Analysis Summary (SFAS) Matrix - With reprioritization, quantification & ranking of respective strategic factors deriving from IFAS & EFAS matrices

  • Quantified Sources of Strengths which could be Leveraged
  • Quantified Weaknesses to be Worked Upon
  • Top Opportunities to be Capitalized Upon & their Quantification to Assess Degree of Relevance & Usefulness
  • Key Existing & Emerging Threats to be Mitigated, Negated & Overcome & their Quantification to Assess Potential Degree of Impact

Section - 6 Comparative Ranking of Industry Players - based on SFAS Scores

1. Airbus SE

2. BAE Systems plc

3. Rolls Royce Holdings plc

4. Leonardo S.p.A.

5. Safran SA

Section - 7 Global Aerospace & Defense Market - Force Field Analysis - Analysis of Driving & Restraining Forces and their Overall Dynamics

Section - 8 Key Market & Technology Trends - Analysis of Key Trends poised to Shape & Transform the future

Section - 9 Key Issues, Challenges & Risk Factors

Section - 10 Strategic Market Outlook - Global Aerospace & Defense Market

10.1 Analysis of Emerging Market Scenario for Aerospace & Defense

10.2 Global Defense Spending Trends

10.3 Top 5 Defense Spending Nations & Defense Budgetary Trends

10.4 Key Growth & Technology Investment Priority Areas

10.5 Key Upcoming Defense Programs

10.6 Emerging Technologies

10.7 Market Outlook & Growth Projections

For more information about this report visit https://www.researchandmarkets.com/r/xh22wi

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom